Study finds Ozempic used for weight loss, diabetes in Canada [Video]

Roughly one million Canadians are using a GLP-1 type drug like Ozempic to manage weight loss and Type 2 diabetes, according to a new survey from Dalhousie University’s Agri-Food Analytics Lab.

A news release from Dalhousie says the national survey, conducted with marketing research firm Caddle, gathered responses from 8,662 Canadians. It determined 10 per cent of the adult population in Canada uses a GLP-1 type drug, which the surveyors estimate means between 900,000 and 1.4 million Canadians are currently using it.

According to the survey, 57.2 per cent of respondents used the drug for Type 2 diabetes, 27.2 per cent use it for weight loss, and 11.6 per cent use it for both.